Literature DB >> 11724439

Frequency data for the STR locus ACTBP2 (SE33) in eight populations.

A Lászik1, P Sótonyi, S Rand, C Hohoff.   

Abstract

Allele frequency data for the STR system ACTBP2 (SE33) were determined in eight populations by denaturing polyacrylamide gel electrophoresis with automated laser-induced fluorescence detection. No significant deviations from Hardy-Weinberg equilibrium were observed. The power of discrimination and the mean exclusion chance ranged from 96.6% to 98.7% and from 76.3% to 88.9%, respectively. These forensic efficiency values stress the importance of ACTBP2 for individualisation purposes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724439     DOI: 10.1007/s004140100209

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  4 in total

1.  Development of the AmpFISTR SEfiler PCR amplification kit: a new multiplex containing the highly discriminating ACTBP2 (SE33) locus.

Authors:  Sulekha Rao Coticone; Nicola Oldroyd; Heidi Philips; Paul Foxall
Journal:  Int J Legal Med       Date:  2004-05-15       Impact factor: 2.686

2.  Allelic drop-out in the STR system ACTBP2 (SE33) as a result of mutations in the primer binding region.

Authors:  Marielle Heinrich; Miriam Müller; Steven Rand; Bernd Brinkmann; Carsten Hohoff
Journal:  Int J Legal Med       Date:  2004-08-20       Impact factor: 2.686

3.  Meiosis study in a population sample from Afghanistan: allele frequencies and mutation rates of 16 STR loci.

Authors:  Carsten Hohoff; Marianne Schürenkamp; Torsten Börchers; Marjon Eppink; Bernd Brinkmann
Journal:  Int J Legal Med       Date:  2006-07-13       Impact factor: 2.686

4.  Chimerism of metanephric adenoma but not of carcinoma in kidney transplants.

Authors:  Michael Mengel; Danny Jonigk; Ludwig Wilkens; Jörg Radermacher; Reinhard von Wasielewski; Ulrich Lehmann; Hermann Haller; Michael Mihatsch; Hans Kreipe
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.